Among patients with immune-mediated diseases and a history of malignancy, cancer recurrence rates were similar regardless of whether they received tum... More »
Women with BRCA1 mutations who undergo risk-reducing ovary and fallopian tube removal without concomitant hysterectomy appear to be at increased risk ... More »
Premenopausal risk-reducing salpingo-oophorectomy becomes cost-effective in women who have a 4% or greater lifetime risk of ovarian cancer, according ... More »
Endorectal balloons appeared to protect against rectal complications from prostate cancer radiation in a small randomized trial from Australia that wa... More »
PARIS – Cancer survivors who subsequently undergo percutaneous coronary intervention are more likely to die of their cardiovascular disease than mal... More »
Genetic counseling by telephone was noninferior to in-person counseling among women at increased risk of hereditary breast and/or ovarian cancer (HBOC... More »
Tyrosine kinase inhibitors were associated with a significantly increased risk of cardiovascular events among chronic myeloid leukemia patients.... More »
The oral immunotherapy tasquinimod improved radiographic progression-free survival (rPFS) in men with metastatic castration-resistant prostate cancer ... More »
Among older adults with acute myeloid leukemia, the combination of a drug-antibody conjugate and hypomethylating therapy was associated with high comp... More »
